Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

HAE holding history

Haemonetics Corp in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HAE overviewAll 13F holders of HAEFull Q2 2026 holdings

Shares (Q2 2026)
1,510,120
Value
$113.3M
% of portfolio
0.1%
Quarters held
20
Since Q1 2021
Holdings of HAE by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,510,120$113.3M0.1%+1,251,967+485.0%AddedHolders
Q1 2026258,153$14.5M<0.1%−1,030,279−80.0%ReducedHolders
Q4 20251,288,432$103.3M0.1%+1,067,004+481.9%AddedHolders
Q3 2025221,428$10.8M<0.1%−31,205−12.4%ReducedHolders
Q2 2025252,633$18.8M<0.1%−105,547−29.5%ReducedHolders
Q1 2025358,180$22.8M<0.1%+168,736+89.1%AddedHolders
Q4 2024189,444$14.8M<0.1%−151,873−44.5%ReducedHolders
Q3 2024341,317$27.4M<0.1%+139,795+69.4%AddedHolders
Q2 2024201,522$16.7M<0.1%+183,991+1,049.5%AddedHolders
Q1 202417,531$1.50M<0.1%+17,531NewHolders
Q4 20230$00.0%−1,768−100.0%Sold outHolders
Q3 20231,768$158.4K<0.1%+77+4.6%AddedHolders
Q2 20231,691$144.0K<0.1%−646−27.6%ReducedHolders
Q1 20232,337$193.4K<0.1%−3,225−58.0%ReducedHolders
Q4 20225,562$437.5K<0.1%−2,319−29.4%ReducedHolders
Q3 20227,881$583.0K<0.1%−630,563−98.8%ReducedHolders
Q2 2022638,444$41.6M0.1%+638,444NewHolders
Q1 20220$00.0%−210,575−100.0%Sold outHolders
Q4 2021210,575$11.2M<0.1%+152,736+264.1%AddedHolders
Q3 202157,839$4.08M<0.1%−137,639−70.4%ReducedHolders
Q2 2021195,478$13.0M<0.1%+178,953+1,082.9%AddedHolders
Q1 202116,525$1.83M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.